Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor
about
Etiology and pathogenesis of uterine leiomyomas: a reviewlncRNA/MicroRNA interactions in the vasculatureFibroblast growth factor signaling in the vasculatureA new synthetic FGF receptor antagonist inhibits arteriosclerosis in a mouse vein graft model and atherosclerosis in apolipoprotein E-deficient miceCarvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injuryTroglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasiaThe cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritisFRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expressionNeointima formation in a restenosis model is suppressed in midkine-deficient miceThe Fat1 cadherin integrates vascular smooth muscle cell growth and migration signalsBasic fibroblast growth factor decreases elastin gene transcription in aortic smooth muscle cellsATF-1 mediates protease-activated receptor-1 but not receptor tyrosine kinase-induced DNA synthesis in vascular smooth muscle cellsIntegrin-linked kinase in the vascular smooth muscle cell response to injuryAn essential role of the Jak-2/STAT-3/cytosolic phospholipase A(2) axis in platelet-derived growth factor BB-induced vascular smooth muscle cell motilityThe role of angiogenic factors in fibroid pathogenesis: potential implications for future therapySerum stimulation, cell-cell interactions, and extracellular matrix independently influence smooth muscle cell phenotype in vitro.A-myb is expressed in bovine vascular smooth muscle cells during the late G1-to-S phase transition and cooperates with c-myc to mediate progression to S phase.Potential for transcatheter application of antisense oligonucleotides for the treatment of vascular diseases.FGFR1 forms an FRS2-dependent complex with mTOR to regulate smooth muscle marker gene expression.Expression of cell cycle regulators during smooth muscle cell proliferation after balloon catheter injury of rat arteryEffect of basic fibroblast growth factor and cytochrome c peroxidase combination in transgenic mice corneal epithelial healing process after excimer laser photoablation.Inhibitory effects of ginsenosides on basic fibroblast growth factor-induced melanocyte proliferation.The mechanisms of coronary restenosis: insights from experimental models.Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibersVascular smooth cell proliferation in perfusion culture of porcine carotid arteriesLong-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes.Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role.Far-infrared therapy induces the nuclear translocation of PLZF which inhibits VEGF-induced proliferation in human umbilical vein endothelial cells.Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury modelFibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury.Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques.Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factorPharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteriesBasic fibroblast growth factor decreases type V/XI collagen expression in cultured bovine aortic smooth muscle cells.Effect of age on the biomechanical and microcirculatory properties of the skin in healthy individuals and during venous ulceration.Nitric oxide inhibits neointimal hyperplasia following vascular injury via differential, cell-specific modulation of SOD-1 in the arterial wall
P2860
Q24815132-1956032D-9126-4D20-9110-D3FC5F1DAD47Q26766577-04B4C305-6279-47AA-96DD-A642E3FA3571Q27011668-7AB2A54D-9FCF-4DFB-A61D-0373A8001708Q27302261-FF8BDCBB-9E72-40A8-A05F-9AAA6CEF6C7EQ28378543-CA029480-40CC-4712-943B-44B40C24F925Q28379241-79C11B61-2BB6-46DF-B6F9-3AEB0151B35BQ28568995-D70B2A1C-9FEF-4FA3-8083-7BDF298AF0F2Q28572993-5966EDEB-4F92-42C6-99FD-A19A17DEC189Q28573235-FC859A08-F1AD-4CAD-85CB-6AAC30ACF586Q28575029-E405F8A8-4DA7-4988-B2BB-DAABD2E0311EQ28577381-7D5D79C3-B845-4354-8D66-11BD85745B5BQ28581381-9F922C98-5A64-4583-B6E5-DB8349369006Q28581550-D5DF8E3D-A343-4487-BE49-8405B3689AC4Q28582726-347E6F9A-BD18-4443-A8D1-63DEC25B310EQ29040166-2BA285AB-1D14-4783-8DB1-EFA58141C4A6Q30445019-5BDF8B42-1810-4447-A52A-B677329948BBQ30452673-5D26C023-4B92-44B7-9F32-020CF7A82C26Q33568857-34EA4922-5AED-4BDB-BD2B-9B8C14F784A4Q33576154-8DF61989-17A7-486F-AE23-A9788CEB53B6Q33631516-0CD3E621-8116-4E0C-81DA-22719CA79894Q33840872-B388AB7F-211A-4048-B9E3-6F7A57325EC6Q33849947-952E5369-5948-47E1-9CBE-52D7D5905C7FQ33890371-F839750A-D048-4ED5-B8A8-DEBC01907564Q34025219-5A3984E9-0FAA-419C-AD6F-9DF52773914BQ34078609-4DD2794F-FEAC-45EB-82DD-F2F317D885D1Q34125214-BD6DF458-4021-420F-82C2-5DD33553CBF6Q34125421-3E8E4FBB-2C52-4ACD-B45B-5DD3B8B817C1Q34133039-399C3DE5-4A25-4C27-BCF4-EC4D5EDD3DB2Q34138108-8ACEECA5-E051-408F-92A1-1DF99BEDD11DQ34138172-8CD83824-0B1A-431C-A33E-C077B1F56F2EQ34146292-EF474D8F-E56F-4A00-9B60-62799581AD3CQ34150085-1DAC7531-0C0E-4AE6-AF2B-8AF94B594B3EQ34196093-8D50EB83-2AF7-41B3-84D4-184E9A9BE46CQ34196344-8133D07D-C26F-4B15-A3C9-2B5A9832E53AQ34228938-37C2BF53-AE50-4718-AC04-912A9C342A8BQ34235387-A98A6FC9-C83C-4F02-A2E4-98EC59F2F1A9Q34405720-14BF0FF3-0102-4EAB-A6D5-D4F2CBDB7FE2Q34453782-B37C35D7-0D17-4BE0-8FD0-06DE5D4E4B26Q34941681-A5CE6195-0C1A-44E2-9F08-613843C7951AQ35007520-795DB7C9-5B7F-43F7-AA9C-65687154DD0F
P2860
Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor
description
1991 nî lūn-bûn
@nan
1991 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Proliferation of smooth muscle ...... basic fibroblast growth factor
@ast
Proliferation of smooth muscle ...... basic fibroblast growth factor
@en
Proliferation of smooth muscle ...... basic fibroblast growth factor
@nl
type
label
Proliferation of smooth muscle ...... basic fibroblast growth factor
@ast
Proliferation of smooth muscle ...... basic fibroblast growth factor
@en
Proliferation of smooth muscle ...... basic fibroblast growth factor
@nl
prefLabel
Proliferation of smooth muscle ...... basic fibroblast growth factor
@ast
Proliferation of smooth muscle ...... basic fibroblast growth factor
@en
Proliferation of smooth muscle ...... basic fibroblast growth factor
@nl
P2860
P356
P1476
Proliferation of smooth muscle ...... basic fibroblast growth factor
@en
P2093
P2860
P304
P356
10.1073/PNAS.88.9.3739
P407
P577
1991-05-01T00:00:00Z